Tafluprost

FDA Approved: * January 28, 2022
Pharm Company: * SANDOZ INC
Category: Vision / Eye Health

Tafluprost (trade names Taflotan by Santen Pharmaceutical and Zioptan by Merck in the US) is a prostaglandin analogue. It is used topically (as eye drops) to control the progression of open-angle glaucoma and in the management of ocular hypertension, alone or in combination with other medication. It reduces intraocular pressure by increasing the outflow of aqueous fluid from the eyes.[1][2] Contents 1 Adverse effects 2 Interactions 3 Pharmacology 3.1 Mechani... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Tafluprost .0045 mg/.3ml Ophthalmic Solution/ Drops
NDC: 0781-6184
Labeler:
Sandoz Inc
Tafluprost .0045 mg/.3ml Ophthalmic Solution/ Drops
NDC: 42571-264
Labeler:
Micro Labs Limited
Tafluprost .015 mg/ml Ophthalmic Solution/ Drops
NDC: 50742-339
Labeler:
Ingenus Pharmaceuticals, LLC
Tafluprost .0045 mg/.3ml Ophthalmic Solution
NDC: 65302-062
Labeler:
The Ritedose Corporation
Tafluprost Ophthalmic Ophthalmic .0045 mg/.3ml Ophthalmic Solution/ Drops
NDC: 66993-429
Labeler:
Prasco Laboratories

Related Brands

Drugs with the same active ingredients

Popular Topics

tafluprost

pharmacokinetic and pharmacodynamic...